By Martin Mou
Jiangsu Hengrui Medicine Co.'s net profit for the first nine months of the year rose 14% on stronger revenue.
Net profit was 4.26 billion yuan ($637.5 million), while revenue grew 15% to CNY19.41 billion, the Chinese drug maker said late Monday.
Hengrui, a major producer of antineoplastic agents and surgical anesthesia drugs in China, didn't specify the factors leading to the improved results.
Write to Martin Mou at martin.mou@wsj.com
(END) Dow Jones Newswires
10-19-20 2114ET